News

STAT13d
Assessing the impact of Trump’s first 100 days on science and health policy
STAT editors and reporters review the widespread impact of grant cuts, layoffs and policy changes — and also discuss recent ...
Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?
Investors often view Pharmaceutical stocks as safe havens during periods of market turbulence. Indeed, shares of the three ...
'Declare victory and move on': Eli Lilly CEO on Trump tariff threat
Eli Lilly (LLY) is among the list of large-cap pharmaceutical companies that are awaiting the Trump administration's word on ...
BioSpace1d
White House Unwraps Massive Drug Pricing Policy, Touching All Corners of Pharma
The package revives President Donald Trump’s much-maligned Most Favored Nation rule but goes further into the private markets ...
Daily Journal3d
Hoosier business executives say to voice tariff concerns, find alternative trade pathways
Business leaders from major Hoosier companies say they are trying to navigate the uncertain trade environment created by ...
President Trump Just Announced Terrible News for Eli Lilly Investors
Now, this won't come as too much of a surprise to Eli Lilly and its peers. A few weeks ago, the company's CEO, David Ricks, ...
FACT FOCUS: Trump Blames Other Countries for High US Drug Prices. Experts Say It's Not Their Fault
President Donald Trump signed an executive order this week setting a 30-day deadline for drugmakers to electively lower ...
Politifact5h
Donald Trump exaggerates speed, certainty of prescription drug price reductions
According to the timeline laid out in President Donald Trump’s May 12 executive order, prescription drug price reductions would not happen "almost immediately." The order specifies a 30-day period to ...